SCHEMBL5468515

SCHEMBL5468515

CCNC(=O)C(S)C(S)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 4/20 0.50
▸ MAPT P10636 3/20 0.50
▸ HPGD P15428 2/20 0.50
▸ HSD17B10 Q99714 2/20 0.50
▸ ALDH1A1 P00352 2/20 0.50
▸ LMNA P02545 2/20 0.50
▸ KDM4E B2RXH2 2/20 0.50
▸ ALOX15 P16050 2/20 0.50
▸ ABCB11 O95342 1/20 0.50
▸ F2 P00734 1/20 0.50
▸ MEN1 O00255 1/20 0.50
▸ KMT2A Q03164 1/20 0.50
▸ DUSP3 P51452 1/20 0.50
▸ PTPN5 P54829 1/20 0.50
▸ PTPN11 Q06124 1/20 0.50
▸ CYP2C9 P11712 1/20 0.50
▸ HIF1A Q16665 1/20 0.50
▸ ACE P12821 5/20 0.46
▸ MME P08473 4/20 0.46
▸ CPA1 P15085 4/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5461356 0.91 ACE (0.47) TDP1MAPTHPGDHSD17B10ALDH1A1
SCHEMBL5471965 0.83 TDP1 (0.46) TDP1MAPTHPGDHSD17B10ALDH1A1
SCHEMBL5458833 0.79 FNTA (0.46) TDP1MAPTHPGDHSD17B10ALDH1A1
SCHEMBL5471451 0.78 CYP2D6 (0.52) TDP1MAPTHPGDHSD17B10ALDH1A1
SCHEMBL5466076 0.77 TDP1 (0.44) TDP1MAPTHPGDHSD17B10ALDH1A1
SCHEMBL3291470 0.76 ALDH1A1 (0.48) TDP1MAPTHPGDHSD17B10ALDH1A1
SCHEMBL3297498 0.76 ALDH1A1 (0.50) TDP1MAPTHPGDHSD17B10ALDH1A1
SCHEMBL5463173 0.76 ALDH1A1 (0.52) TDP1MAPTHPGDHSD17B10ALDH1A1
SCHEMBL5456318 0.75 LAP3 (0.54) TDP1MAPTHPGDHSD17B10ALDH1A1
SCHEMBL5465770 0.74 RNPEP (0.45) TDP1MAPTALDH1A1LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070009462-A9 Composition to permanently reshape the hair containing at least one dicarboxydithiol MALLE GERARD 2007-01-11 — — US claimed
US-20050201964-A1 Composition to permanently reshape the hair containing at least one dicarboxydithiol L'OREAL S.A. (FR) 2005-09-15 — — US claimed
US-20070009462-A9 Composition to permanently reshape the hair containing at least one dicarboxydithiol MALLE GERARD 2007-01-11 — — US disclosed
US-20050201964-A1 Composition to permanently reshape the hair containing at least one dicarboxydithiol L'OREAL S.A. (FR) 2005-09-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050201964-A1 Composition to permanently reshape the hair containing at least one dicarboxydithiol NR5A1, SRD5A2, HRH3 TDP1 2922/4885MAPT 3323/4885HPGD 487/4885
US-20070009462-A9 Composition to permanently reshape the hair containing at least one dicarboxydithiol NR5A1, SRD5A2, HRH3 TDP1 2922/4885MAPT 3323/4885HPGD 487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback